Abstract
THE molecule CD23, a low-affinity receptor for IgE (FcεR2)1,2, is a type II transmembrane molecule expressed on many haemopoietic cell types3,4. CD23 has pleiotropic roles in the control of lymphocyte behaviour5–9, suggesting that CD23 may interact with another ligand in addition to IgE. To identify such a CD23 ligand, we expressed and purified full-length recombinant CD23, incorporated it into fluorescent liposomes and used these as a probe. We report here that fluorescent liposomes carrying CD23 interact specifically with the cell-surface protein CD21, identified as the receptor for Epstein–Barr virus and the complement recep-tor-2 on B cells, some T cells and follicular dendritic cells. In addition, fluorescent CD23–liposomes were shown to bind to ham-ster kidney cells (BHK-21) transfected with CD21 complementary DNA. The interaction between fluorescent CD23–liposomes and B cells or CD21-transfected BHK-21 cells was specifically inhibited by anti-CD21 and anti-CD23 monoclonal antibodies. Western blotting analysis revealed that 14C-labelled liposomes carrying CD23, in contrast to anti-CD21 antibodies, reacted with a subtype of CD21 molecules. Triggering of CD21 either with an anti-CD21 antibody or with recombinant soluble CD23 was shown to increase specifically interleukin-4-induced IgE production from blood mononuclear cells. These results demonstrate that the cell-surface protein CD21 is a ligand for CD23 and that the pairing of these molecules may participate in the control of IgE production.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Yukawa, K. et al. J. Immun. 138, 2576–2580 (1987).
Bonnefoy, J.-Y., Aubry, J.-P., Perrone, C., Wijdenes, J. & Banchereau, J. J. Immun. 138, 2970–2978 (1987).
Gordon, J. et al. Immun. Today 10, 153–157 (1989).
Delespesse, G., Sarfati, M. & Hofstetter, H. Immun. Today 10, 159–164 (1989).
Cairns, J. & Gordon, J. Eur. J. Immun. 20, 534–543 (1990).
Jansen, K. U. et al. J. Rec. Res. 11, 507–520 (1991).
Liu, Y.-J. et al. Eur. J. Immun. 21, 1107–1114 (1991).
Mossalayi, M. D. et al. J. exp. Med. 171, 959–964 (1990).
Mossalayi, M. D. et al. Blood 75, 1924–1927 (1990).
Gordon, J., Rowe, M., Walker, L. & Guy, G. Eur. J. Immun. 16, 1075–1080 (1986).
Flores-Romo, L. et al. Eur. J. Immun. 20, 2465–2469 (1990).
Bonnefoy, J.-Y. et al. J. exp. Med. 176, 57–72 (1988).
Pochon, S. et al. J. exp. Med. (in the press).
Dorken, B., Moller, P., Pezzutto, A., Schwartz-Albiez, R. & Moldenhauer, G. in Leucocyte Typing IV (eds Knapp, W. et al.) 99–100 (Oxford Univ. Press, Oxford, 1989).
Cantaloube, J.-F. et al. Eur. J. Immun. 20, 409–416 (1990).
Ikuta, K. et al. Proc. natn. Acad. Sci. U.S.A. 84, 819–823 (1987).
Pène, J. et al. Proc. natn. Acad. Sci. U.S.A. 85, 6880–6884 (1988).
Bonnefoy, J.-Y., Shields, J. & Mermod, J.-J. Eur J. Immun. 20, 139–144 (1990).
Vercelli, D., Jabara, H. H., Arai, K. I. & Geha R. S. J. exp. Med. 169, 1295–1307 (1989).
Fischer, E., Delibrias, C. & Kazatchkine, M. D. J. Immun. 146, 865–869 (1991).
Pène, J. et al. Eur. J. Immun. 18, 929–935 (1988).
Nadler, L. M. et al. J. Immun. 126, 1941–1947 (1981).
Reynes, M. et al. J. Immun. 135, 2687–2694 (1985).
Young, L. S., Sixbey, J. W., Clark, D. & Rickinson, A. B. Lancet 1, 240–242 (1986).
Weis, J. J., Tedder, T. F. & Fearon, D. T. Proc. natn. Acad. Sci. U.S.A. 81, 881–885 (1984).
Nemerow, G. R., Mold, C., Schwend, V. K., Tollefson, V. & Cooper, N. R. J. Virol. 61, 1416–1420 (1987).
Tanner, J., Weis, J., Fearon, D., Whang, Y. & Kieff, E. Cell 50, 203–213 (1987).
Delcayre, A. et al. EMBO J. 10, 919–926 (1991).
Frade, R., Barel, M., Ehlin-Henriksson, B. & Klein, G. Proc. natn. Acad. Sci. U.S.A. 82, 1490–1493 (1985).
Wilson, B., Platt, J. & Kay, N. Blood 66, 824–829 (1985).
Melchers, F., Erdei, A., Schulz, T. & Dierich, M. P. Nature 317, 264–267 (1985).
Hutt-Fletcher, L. M. J. Virol. 651, 774–781 (1987).
Kolb, J.-P. et al. J. Immun. 145, 429–437 (1990).
Billaud, M. et al. J. Virol. 63, 4121–4128 (1989).
Tew, J. G. & Mandel, T. E. Immunology 37, 69–76 (1979).
Seed, B. & Aruffo, A. Proc. natn. Acad. Sci. U.S.A. 84, 3365–3369 (1987).
Graber, P. et al. J. Immun. Meth. 149, 215–226 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aubry, JP., Pochon, S., Graber, P. et al. CD21 is a ligand for CD23 and regulates IgE production. Nature 358, 505–507 (1992). https://doi.org/10.1038/358505a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/358505a0
This article is cited by
-
Complement as a regulator of adaptive immunity
Seminars in Immunopathology (2018)
-
Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
Nature Communications (2016)
-
Mechanisms of IgE Inflammation
Current Allergy and Asthma Reports (2011)
-
SDF-1 and PDGF enhance αvβ5-mediated ERK activation and adhesion-independent growth of human pre-B cell lines
Leukemia (2009)
-
Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing
Genes & Immunity (2009)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.